Skip to main content

Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · Delayed Price · USD
72.13 1.28 (1.81%)
Sep 22, 2021 4:00 PM EDT - Market closed
Market Cap4.06B
Revenue (ttm)1.03B
Net Income (ttm)28.24M
Shares Out56.06M
EPS (ttm)0.50
PE Ratio144.26
Forward PE29.24
Dividendn/a
Ex-Dividend Daten/a
Volume171,628
Open70.91
Previous Close70.85
Day's Range69.55 - 72.48
52-Week Range39.45 - 73.85
Beta1.25
AnalystsBuy
Price Target76.22 (+5.7%)
Est. Earnings DateOct 27, 2021

About MMSI

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm managemen...

IndustryHealth Care Equipment & Supplies
IPO DateAug 9, 1990
CEOFred Lampropoulos
Employees6,300
Stock ExchangeNASDAQ
Ticker SymbolMMSI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is 76.22, which is an increase of 5.67% from the latest price.

Price Target
$76.22
(5.67% upside)
Analyst Consensus: Buy

News

Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis

Prospective, observational study published in CardioVascular and Interventional Radiology 1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-mon...

2 days ago - GlobeNewsWire

3 Dental Stocks Poised to Perform Well in Second-Half 2021

Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.

Other symbols:ALGNHSICWST
6 days ago - Zacks Investment Research

Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

3 weeks ago - Zacks Investment Research

Merit Medical (MMSI) Expands Drainage Portfolio With New Product

Merit Medical's (MMSI) new commercial product launch can make sample collection simple, safe and efficient.

1 month ago - Zacks Investment Research

Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard

Advanced design makes sample collection simple, efficient, and safe Advanced design makes sample collection simple, efficient, and safe

1 month ago - GlobeNewsWire

Merit Medical (MMSI) is a Great Momentum Stock: Should You Buy?

Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.

1 month ago - Zacks Investment Research

Merit Medical (MMSI) Hits Fresh High: Is There Still Room to Run?

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

1 month ago - Zacks Investment Research

Merit Medical's (MMSI) Q2 Earnings Top Estimates, '21 View Up

Merit Medical (MMSI), in the second quarter, benefits from revenue growth across both its segments as well as across all the product categories within its Cardiovascular unit.

1 month ago - Zacks Investment Research

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 40.91% and 11.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Merit Medical Reports Results for Quarter Ended June 30, 2021

* Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-...

1 month ago - GlobeNewsWire

Merit Medical (MMSI) Reports Next Week: Wall Street Expects Earnings Growth

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Here's Why You Should Retain Merit Medical (MMSI) Stock Now

Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.

2 months ago - Zacks Investment Research

Merit Medical Systems to Announce Second Quarter Results on July 29, 2021

SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic...

2 months ago - GlobeNewsWire

Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on

These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.

Other symbols:ABTBDXBSXEWMDT
3 months ago - Zacks Investment Research

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

Investors continue to be optimistic about Merit Medical (MMSI), owing to its potential in the Peripheral Intervention arm and strong international foothold.

3 months ago - Zacks Investment Research

Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates

Merit Medical (MMSI) benefits from growth in revenues at the Cardiovascular segment in Q1.

4 months ago - Zacks Investment Research

Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 40.54% and 7.73%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Merit Medical Systems: Q1 Earnings Insights

Shares of Merit Medical Systems (NASDAQ:MMSI) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 36.84% year over year to $0.52, whic...

4 months ago - Benzinga

Merit Medical Reports Results for Quarter Ended March 31, 2021

*  Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non...

4 months ago - GlobeNewsWire

Merit Medical Systems Earnings Preview

Merit Medical Systems (NASDAQ:MMSI) releases its next round of earnings this Thursday, April 29. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.

4 months ago - Benzinga

Earnings Preview: Merit Medical (MMSI) Q1 Earnings Expected to Decline

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Dental Market Shows Strength Despite Pandemic: 3 Stocks to Watch

Let's keep a watch on three lucrative stocks, XRAY, MCK and MMSI, in the dental space that have performed impressively despite the pandemic-led volatility.

Other symbols:ALGNMCKXRAY
5 months ago - Zacks Investment Research

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Merit Medical Systems, I...

LOS ANGELES--(BUSINESS WIRE)---- $MMSI #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announces that it has commenced an investigation of potent...

5 months ago - Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $MMSI #investors--The Law Offices of Frank R. Cruz Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors

5 months ago - Business Wire

INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Merit Medical Systems, Inc.

NEW YORK--(BUSINESS WIRE)---- $MMSI--The law firm of Kirby McInerney LLP is investigating claims against Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation ...

5 months ago - Business Wire